IBRAHIM NK, 1995, Am.,/ Gin. Oncoi (CCP), 18, 407
EVANS CT, 1986, Proc. Nati Acad. Sci. USA, 83, 6387, 10.1073/pnas.83.17.6387
REED MJ, 1994, Breast. Cancer. Res. Treat., 30, 7, 10.1007/BF00682737
SIMPSON ER, 2002, Ann. Rev Physiol., 64, 93, 10.1146/annurev.physiol.64.081601.142703
LONNING PE, 2001, Br. Med., 323, 880, 10.1136/bmj.323.7318.880
ALLRED DC, 2003, Breast J., 9, 213, 10.1046/j.1524-4741.2003.09305.x
GOSS PE, 2003, Jim. Clin. Oncol., 26, S27–S33
GOSS PE, 2001, J. Clin. Oncol, 19, 881, 10.1200/JCO.2001.19.3.881
DOWSETT M, 1995, Clin. Canc. Res., 1, 1511
GEISLER J, 1996, Br J. Cancer, 74, 1286, 10.1038/bjc.1996.531
GEISLER J, 1998, Clin. Cancer Res., 4, 2089
CHEN S, 1999, Endoct: Reim. Cancer, 6, 149
MURRAY P, 1995, Breast. Cancer Res. Treat., 35, 249, 10.1007/BF00665976
GEISLER J, 1996, Eur. .1. Cancer, 32, 789, 10.1016/0959-8049(95)00623-0
LONNING PE, 2000, Clin Oncol, 8, 2234, 10.1200/JCO.2000.18.11.2234
10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.3.CO;2-7
DOMBERNOWSKY P, 1998, J. Clin. Oncol, 16, 453, 10.1200/JCO.1998.16.2.453
KAUFMANN M, 2000, I. Clin. Oncol., 18, 1399, 10.1200/JCO.2000.18.7.1399
NABHOLTZ JM, 2000, " Clin. Oncol, 18, 3758, 10.1200/JCO.2000.18.22.3758
BONNETERRE J, 2000, j Clin. Oncol, 18, 3748, 10.1200/JCO.2000.18.22.3748
PARIDAENS R, 2002, Clin. Breast. Cancer, 1, 519
THE ATAC, 2002, Lancet, 359, 2131, 10.1016/S0140-6736(02)09088-8
POWLES TJ, 1996, " Clin. Oncol, 14, 78, 10.1200/JCO.1996.14.1.78
LOVE RR, 1994, Arch. Intern. Med., 154, 2585, 10.1001/archinte.1994.00420220081009
HARPER-VVYNNE C, 2002, Cancer Epidemiol Biomarkers. Prey., 11, 614
LONNING P, 2003, Pharmacokinet., 42, 619, 10.2165/00003088-200342070-00002
MORTIMER JE, 2003, Oncology (Hunting), 17, 652
DIXON JM, 2002, Eur. J. Cancer., 38, 2214, 10.1016/S0959-8049(02)00265-4
